• Immunofluorescence analysis of HUVEC cells, using GRID2 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of lysates from mouse brain, using GRID2 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of 3T3 cells using GluR-Delta 2 Polyclonal Antibody

Anti-GRID2 antibody (831-880 aa) (STJ93292)

SKU:
STJ93292

Current Stock:
Host: Rabbit
Applications: WB/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Glutamate receptor ionotropic, delta-2 (831-880 aa) is suitable for use in Western Blot, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IF 1:200-1:1000
ELISA 1:20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: GRID2
Gene ID: 2895
Uniprot ID: GRID2_HUMAN
Immunogen Region: 831-880 aa
Specificity: GluR-Delta 2 Polyclonal Antibody detects endogenous levels of GluR-Delta 2 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human GRID2 at the amino acid range 831-880
Protein Name Glutamate Receptor Ionotropic - Delta-2
Glud2
Glur Delta-2 Subunit
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Postsynaptic Cell Membrane
Alternative Antibody Names Anti-Glutamate Receptor Ionotropic - Delta-2 antibody
Anti-Glud2 antibody
Anti-Glur Delta-2 Subunit antibody
Anti-GRID2 antibody
Anti-GLURD2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance